Ridgecrest Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
4,221
-50
-1% -$17.8K 0.82% 30
2025
Q4
$1.4M Sell
4,271
-356
-8% -$113K 0.76% 28
2025
Q3
$1.31M Sell
4,627
-250
-5% -$72.5K 0.59% 33
2025
Q2
$1.36M Hold
4,877
0.72% 32
2025
Q1
$1.52M Buy
4,877
+450
+10% +$133K 0.8% 30
2024
Q4
$1.15M Buy
4,427
+239
+6% +$70.9K 0.63% 33
2024
Q3
$1.35M Buy
4,188
+45
+1% +$14.7K 0.7% 30
2024
Q2
$1.29M Sell
4,143
-40
-1% -$11.8K 0.78% 28
2024
Q1
$1.19M Sell
4,183
-35
-0.8% -$10.2K 0.71% 32
2023
Q4
$1.21M Sell
4,218
-440
-9% -$120K 0.8% 30
2023
Q3
$1.25M Hold
4,658
0.88% 27
2023
Q2
$1.03M Buy
4,658
+90
+2% +$20.9K 0.68% 30
2023
Q1
$1.1M Hold
4,568
0.79% 30
2022
Q4
$1.2M Sell
4,568
-25
-0.5% -$6.7K 0.91% 28
2022
Q3
$1.03M Hold
4,593
0.84% 29
2022
Q2
$1.12M Hold
4,593
0.81% 32
2022
Q1
$1.11M Buy
4,593
+150
+3% +$34.5K 0.71% 37
2021
Q4
$1M Buy
4,443
+1,850
+71% +$390K 0.49% 47
2021
Q3
$551K Buy
2,593
+464
+22% +$107K 0.3% 65
2021
Q2
$519K Buy
2,129
+461
+28% +$113K 0.32% 62
2021
Q1
$415K Buy
+1,668
New +$398K 0.4% 53

Other funds holding AMGN

Ridgecrest Wealth Partners's AMGN Position: Q1 2026 in Review

Ridgecrest Wealth Partners reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $17.8K and leaving 4,221 shares worth $1.49M. The position accounts for 0.82% of the portfolio, ranked #30.

Ridgecrest Wealth Partners first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.52M in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ridgecrest Wealth Partners held 4,221 shares of Amgen worth $1.49M as of Q1 2026.
  • Ridgecrest Wealth Partners sold 50 Amgen shares in Q1 2026, an estimated $17.8K.
  • Amgen made up 0.82% of Ridgecrest Wealth Partners's portfolio in Q1 2026, its #30 holding.
  • Ridgecrest Wealth Partners first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
  • Ridgecrest Wealth Partners's Amgen position peaked at $1.52M in Q1 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.